Orient Europharma Co Ltd (4120) — Long-term Investment Intensity
Orient Europharma Co Ltd (4120) has a Long-term Investment Intensity of 1.9% as of December 2019. Long-term investments of NT$145.70 Million represent 1.9% of total assets of NT$7.87 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Orient Europharma Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Orient Europharma Co Ltd Long-term Investment Intensity (2015–2019)
This chart shows how Orient Europharma Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 1.9%, reflecting long-term investments of NT$145.70 Million against total assets of NT$7.87 Billion TWD. Explore cash flow to debt ratio of Orient Europharma Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Orient Europharma Co Ltd (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for Orient Europharma Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Orient Europharma Co Ltd worth.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.9% | NT$145.70 Million | NT$7.87 Billion | ▲ +0.4 pp |
| 2018 | 1.5% | NT$107.30 Million | NT$7.24 Billion | ▼ -1.4 pp |
| 2017 | 2.9% | NT$192.14 Million | NT$6.65 Billion | ▼ -1.1 pp |
| 2016 | 4.0% | NT$256.66 Million | NT$6.49 Billion | ▼ -0.6 pp |
| 2015 | 4.5% | NT$248.16 Million | NT$5.47 Billion | — |